Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daphnetin for Lower Limb Lymphoedema
NCT06329167Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daphnetin in Lower-Limb Lymphedema, sponsored by The First Hospital of Jilin University. Started Mar 2024; status: recruiting.
02
Drugs
daphnetin
03
Conditions
Lower-Limb Lymphedema
Beyond the preview
Go deeper on NCT06329167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329167.